Guwahati: One of the potential vaccines against COVID-19 by AstraZeneca, the AstraZeneca plcAZN.L (AZN.L) will provide protection against contracting the infectious virus for only a year. This was told by Pascal Soriot, the CEO of the company on Tuesday, June 16.
The British drugmaker has already started the human trials of the vaccine. The vaccine is created by the University of Oxford, with phase I of the trial in Britain to end soon and phase III trial already making its headway as stated by Soriot.
Also Read: Low-cost steroid Dexamethasone found to reduce COVID-19 deaths
...
Trending Stories
- What is it about Gaza? Wars are raging around the world, so why are young people so passionate about this one?
- KNF reiterates call for separate admin for Kuki-Zo community
- Georgia protests mark Russia’s new frontline with the west
- Red alert: How cinema helps the Modi myth
- Nagaland: Agricultural officer encourages youth to embrace farming
- NagaEd brings internet ‘faster than Bangalore’ to remote villages
